JP2010504908A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010504908A5 JP2010504908A5 JP2009520765A JP2009520765A JP2010504908A5 JP 2010504908 A5 JP2010504908 A5 JP 2010504908A5 JP 2009520765 A JP2009520765 A JP 2009520765A JP 2009520765 A JP2009520765 A JP 2009520765A JP 2010504908 A5 JP2010504908 A5 JP 2010504908A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- alkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000006714 (C3-C10) heterocyclyl group Chemical group 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 241000257303 Hymenoptera Species 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83104206P | 2006-07-14 | 2006-07-14 | |
| US60/831,042 | 2006-07-14 | ||
| US94583907P | 2007-06-22 | 2007-06-22 | |
| US60/945,839 | 2007-06-22 | ||
| PCT/US2007/015808 WO2008010934A2 (en) | 2006-07-14 | 2007-07-10 | Triazolyl phenyl benzenesulfonamides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010504908A JP2010504908A (ja) | 2010-02-18 |
| JP2010504908A5 true JP2010504908A5 (enExample) | 2012-05-24 |
| JP5266219B2 JP5266219B2 (ja) | 2013-08-21 |
Family
ID=38896161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520765A Active JP5266219B2 (ja) | 2006-07-14 | 2007-07-10 | トリアゾリルフェニルベンゼンスルホンアミド類 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP2046762B1 (enExample) |
| JP (1) | JP5266219B2 (enExample) |
| KR (1) | KR101433392B1 (enExample) |
| AT (1) | ATE498615T1 (enExample) |
| AU (1) | AU2007275873B2 (enExample) |
| BR (1) | BRPI0714407A2 (enExample) |
| CA (1) | CA2657776C (enExample) |
| CO (1) | CO6180465A2 (enExample) |
| DE (1) | DE602007012552D1 (enExample) |
| DK (1) | DK2046762T3 (enExample) |
| EA (1) | EA015710B1 (enExample) |
| IL (1) | IL196409A (enExample) |
| MA (1) | MA30690B1 (enExample) |
| MX (1) | MX2009000395A (enExample) |
| NO (1) | NO341949B1 (enExample) |
| NZ (1) | NZ574759A (enExample) |
| PL (1) | PL2046762T3 (enExample) |
| PT (1) | PT2046762E (enExample) |
| UA (1) | UA98304C2 (enExample) |
| WO (1) | WO2008010934A2 (enExample) |
| ZA (1) | ZA200900281B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7683176B2 (en) | 2006-07-14 | 2010-03-23 | Chemocentryx, Inc. | Triazolyl pyridyl benzenesulfonamides |
| CA2677481C (en) | 2007-02-08 | 2015-07-07 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate hsp90 activity |
| TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| WO2010005922A1 (en) * | 2008-07-07 | 2010-01-14 | Fasgen, Inc. | Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same |
| US8343977B2 (en) | 2009-12-30 | 2013-01-01 | Arqule, Inc. | Substituted triazolo-pyrimidine compounds |
| SG192126A1 (en) * | 2011-01-25 | 2013-09-30 | Univ Michigan | Bcl-2/bcl-xl inhibitors and therapeutic methods using the same |
| WO2013016155A1 (en) * | 2011-07-22 | 2013-01-31 | Glaxo Group Limited | Polymorphic forms of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide |
| HUE032747T2 (en) * | 2011-07-22 | 2017-10-30 | Chemocentryx Inc | Crystalline form of the sodium salt of 4-tert-butyl-N- [4-chloro-2- (1-oxypyridine-4-carbonyl) phenyl] benzenesulfonamide |
| JP6166721B2 (ja) * | 2011-07-22 | 2017-07-19 | ケモセントリックス， インコーポレイテッド | ４−ｔｅｒｔ−ブチル−Ｎ−［４−クロロ−２−（１−オキシ−ピリジン−４−カルボニル）−フェニル］−ベンゼンスルホンアミドのナトリウム塩の多形 |
| US20140329809A1 (en) | 2011-10-28 | 2014-11-06 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
| CA2865714C (en) * | 2012-02-29 | 2021-06-15 | Chemocentryx, Inc. | Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists |
| EP2820010B1 (en) * | 2012-03-01 | 2018-05-09 | Allergan, Inc. | Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators |
| ES2735360T3 (es) * | 2013-12-02 | 2019-12-18 | Chemocentryx Inc | Compuestos CCR6 |
| EP3087074A1 (en) | 2013-12-23 | 2016-11-02 | Norgine BV | Benzene sulfonamides as ccr9 inhibitors |
| EP3087069B1 (en) | 2013-12-23 | 2019-01-30 | Norgine B.V. | Compounds useful as ccr9 modulators |
| US10000458B2 (en) * | 2016-03-31 | 2018-06-19 | Sumitomo Chemical Company, Limited | Production method of 1, 2, 4-triazole compound |
| CA3136279A1 (en) | 2019-05-09 | 2020-11-12 | Grey Wolf Therapeutics Limited | Phenyl-sulfamoyl.benzoyc acids as erap1 modulators |
| EP3996711A4 (en) | 2019-07-10 | 2023-08-16 | ChemoCentryx, Inc. | Indanes as pd-l1 inhibitors |
| KR20220084119A (ko) | 2019-10-16 | 2022-06-21 | 케모센트릭스, 인크. | Pd-l1 질환의 치료를 위한 헤테로아릴-바이페닐 아미드 |
| US11866429B2 (en) | 2019-10-16 | 2024-01-09 | Chemocentryx, Inc. | Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases |
| CN115477626B (zh) * | 2021-06-16 | 2024-08-02 | 上海璃道医药科技有限公司 | N-取代苯基磺酰胺类化合物及其用途 |
| JP2024534799A (ja) * | 2021-08-20 | 2024-09-26 | エナンタ ファーマシューティカルズ インコーポレイテッド | １７－ベータ－ヒドロキシステロイドデヒドロゲナーゼ１３型阻害剤及びその使用方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
| US6159686A (en) | 1992-09-14 | 2000-12-12 | Sri International | Up-converting reporters for biological and other assays |
| US5514555A (en) | 1993-03-12 | 1996-05-07 | Center For Blood Research, Inc. | Assays and therapeutic methods based on lymphocyte chemoattractants |
| US6322901B1 (en) | 1997-11-13 | 2001-11-27 | Massachusetts Institute Of Technology | Highly luminescent color-selective nano-crystalline materials |
| US6207392B1 (en) | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| US5990479A (en) | 1997-11-25 | 1999-11-23 | Regents Of The University Of California | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| US6326144B1 (en) | 1998-09-18 | 2001-12-04 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
| US6306610B1 (en) | 1998-09-18 | 2001-10-23 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
| US6251303B1 (en) | 1998-09-18 | 2001-06-26 | Massachusetts Institute Of Technology | Water-soluble fluorescent nanocrystals |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US7468253B2 (en) | 2001-06-07 | 2008-12-23 | Chemocentryx, Inc. | Method for multiple chemokine receptor screening for antagonists using RAM assay |
| JP4233092B2 (ja) | 2001-06-07 | 2009-03-04 | ケモセントリックス， インコーポレイテッド | 細胞移動アッセイ |
| EP2402310A1 (en) | 2002-05-24 | 2012-01-04 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
| CA2500492C (en) * | 2002-11-18 | 2010-03-16 | Solomon Ungashe | Aryl sulfonamides |
| US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| JO2397B1 (en) * | 2002-12-20 | 2007-06-17 | ميرك شارب اند دوم كوربوريشن | Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors |
| US7393873B2 (en) | 2003-07-02 | 2008-07-01 | Merck & Co., Inc. | Arylsulfonamide derivatives |
| WO2005004818A2 (en) * | 2003-07-09 | 2005-01-20 | Imclone Systems Incorporated | Heterocyclic compounds and their use as anticancer agents |
| EP1748989A2 (en) * | 2004-05-12 | 2007-02-07 | ChemoCentryx Inc | Aryl sulfonamides |
| US9715915B2 (en) | 2014-10-30 | 2017-07-25 | Samsung Electronics Co., Ltd. | Magneto-resistive devices including a free layer having different magnetic properties during operations |
-
2007
- 2007-07-10 WO PCT/US2007/015808 patent/WO2008010934A2/en not_active Ceased
- 2007-07-10 EA EA200900168A patent/EA015710B1/ru not_active IP Right Cessation
- 2007-07-10 CA CA2657776A patent/CA2657776C/en active Active
- 2007-07-10 DE DE602007012552T patent/DE602007012552D1/de active Active
- 2007-07-10 MX MX2009000395A patent/MX2009000395A/es active IP Right Grant
- 2007-07-10 JP JP2009520765A patent/JP5266219B2/ja active Active
- 2007-07-10 PL PL07836049T patent/PL2046762T3/pl unknown
- 2007-07-10 BR BRPI0714407-5A patent/BRPI0714407A2/pt not_active Application Discontinuation
- 2007-07-10 EP EP07836049A patent/EP2046762B1/en active Active
- 2007-07-10 KR KR1020097001415A patent/KR101433392B1/ko active Active
- 2007-07-10 AT AT07836049T patent/ATE498615T1/de active
- 2007-07-10 PT PT07836049T patent/PT2046762E/pt unknown
- 2007-07-10 DK DK07836049.2T patent/DK2046762T3/da active
- 2007-07-10 NZ NZ574759A patent/NZ574759A/en not_active IP Right Cessation
- 2007-07-10 AU AU2007275873A patent/AU2007275873B2/en active Active
- 2007-10-07 UA UAA200901182A patent/UA98304C2/uk unknown
-
2009
- 2009-01-08 IL IL196409A patent/IL196409A/en active IP Right Grant
- 2009-01-12 MA MA31566A patent/MA30690B1/fr unknown
- 2009-01-13 ZA ZA2009/00281A patent/ZA200900281B/en unknown
- 2009-02-04 CO CO09010534A patent/CO6180465A2/es active IP Right Grant
- 2009-02-11 NO NO20090662A patent/NO341949B1/no not_active IP Right Cessation